Franzese A, Salerno M, Argenziano A, Buongiovanni C, Limauro R, Tenore A
Dipartimento di Pediatria, Università di Napoli, Italy.
J Endocrinol Invest. 1996 Oct;19(9):613-9. doi: 10.1007/BF03349027.
Although anemia is a common finding in adult hypothyroid patients, there are no studies on anemia in hypothyroid infants. The aim of this study, therefore, was to review the hematologic status during the first year of life in 50 infants with congenital hypothyroidism detected through the regional neonatal screening program. The mean age at diagnosis was 23.7 +/- 6.5 days and treatment was initially begun with a mean L-thyroxine dose of 6.8 +/- 1.3 micrograms/kg/day. Clinical and haematological assessments were performed at diagnosis, 3, 6 and 12 months of age. The patients were divided in 2 groups based on whether T4 serum concentration at diagnosis was < 3 micrograms/dl (Group A) or > or = 3 micrograms/dl (Group B). Data for hemoglobin (Hb), hematocrit (Ht), red cells count (RCC), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), serum iron and ferritin were expressed as Standard Deviation Score (SDS). Although at diagnosis the mean value of Hb-SDS, Ht-SDS and RCC-SDS were in the low-normal range in both groups, at 3 months of age the values in Group A (Hb -1.9 +/- 0.79; Ht -2.34 +/- 1.02; RCC -1.56 +/- 1.25) were significantly lower than in Group B (Hb -1.14 +/- 0.78, p < 0.005; Ht -1.59 +/- 0.94, p < 0.05; RCC -0.55 +/- 1.32, p < 0.02). A rise of the Hb, Ht and RCC values was observed in both groups from 6 to 12 months. The mean values of MCV-SDS and MCH-SDS were in the normal range at diagnosis in both groups, decrease progressively at 3 and 6 months and returned to normal at 12 months of age; no differences were found between the 2 groups at any time. Mean Hb levels at 3 months of age were correlated with mean serum T4 at diagnosis (r = 0.30, p < 0.05). The present results indicate that anemia is a frequent finding in infants with congenital hypothyroidism and is depended on the degree of neonatal hypothyroidism and imply that hypothyroidism during development may produce persisting changes even after thyroid replacement has begun.
虽然贫血在成年甲状腺功能减退患者中很常见,但尚无关于甲状腺功能减退婴儿贫血情况的研究。因此,本研究的目的是回顾通过区域新生儿筛查项目检测出的50例先天性甲状腺功能减退婴儿在出生后第一年的血液学状况。诊断时的平均年龄为23.7±6.5天,最初开始治疗时左甲状腺素的平均剂量为6.8±1.3微克/千克/天。在诊断时、3个月、6个月和12个月时进行临床和血液学评估。根据诊断时血清T4浓度是否<3微克/分升(A组)或≥3微克/分升(B组)将患者分为两组。血红蛋白(Hb)、血细胞比容(Ht)、红细胞计数(RCC)、平均红细胞体积(MCV)、平均红细胞血红蛋白(MCH)、血清铁和铁蛋白的数据以标准差评分(SDS)表示。虽然在诊断时两组的Hb-SDS、Ht-SDS和RCC-SDS的平均值均处于低正常范围,但在3个月大时,A组的值(Hb -1.9±0.79;Ht -2.34±1.02;RCC -1.56±1.25)显著低于B组(Hb -1.14±0.78,p<0.005;Ht -1.59±0.94,p<0.05;RCC -0.55±1.32,p<0.02)。两组在6至12个月时Hb、Ht和RCC值均有所上升。两组在诊断时MCV-SDS和MCH-SDS的平均值均在正常范围内,在3个月和6个月时逐渐下降,并在12个月时恢复正常;两组在任何时候均未发现差异。3个月大时的平均Hb水平与诊断时的平均血清T4相关(r = 0.30,p<0.05)。目前的结果表明,贫血在先天性甲状腺功能减退婴儿中很常见,且取决于新生儿甲状腺功能减退的程度,这意味着发育期间的甲状腺功能减退即使在开始甲状腺替代治疗后也可能产生持续的变化。